Looking for leads, investment insights, or competitive intelligence?
News about Bayer
Bayer bought the chemical company earlier this year.
Bayer's $66 billion acquisition closed just months ago.
The company blamed slow sales, but thousands of women have complained about the device.
Must-read business news, delivered every morning.
Russian drugmaker Nativa got a compulsory license to produce a cheaper version of Celgene's Revlimid.